Comparison of modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas in predicting long-term outcomes in patients undergoing stent implantation due to stable coronary artery disease

2014 ◽  
Vol 103 (7) ◽  
pp. 569-576 ◽  
Author(s):  
Tadeusz Osadnik ◽  
Jarosław Wasilewski ◽  
Andrzej Lekston ◽  
Joanna Strzelczyk ◽  
Anna Kurek ◽  
...  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Abou-bakr Abbadi ◽  
Gilles Lemesle ◽  
Nicolas Lamblin ◽  
Christophe Bauters

2004 ◽  
Vol 93 (3) ◽  
pp. 294-299 ◽  
Author(s):  
Samer Jabbour ◽  
Yinong Young-Xu ◽  
Thomas B Graboys ◽  
Charles M Blatt ◽  
Robert J Goldberg ◽  
...  

2016 ◽  
Vol 25 (3) ◽  
pp. 958-966 ◽  
Author(s):  
Hendrik J. Boiten ◽  
Jan C. van den Berge ◽  
Roelf Valkema ◽  
Ron T. van Domburg ◽  
Felix Zijlstra ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-8
Author(s):  
Huiling Huang ◽  
Chunmei Zeng ◽  
Yuedong Ma ◽  
Yili Chen ◽  
Cong Chen ◽  
...  

Introduction.The effect of long-term statin therapy is essential for secondary prevention of adverse clinical outcomes of coronary artery disease (CAD) patients. No study has compared the effects of long-term statin treatment in CAD patients with or without chronic kidney disease (CKD) and CKD only patients.Methods.We compared the effects of long-term statin therapy (average follow-up time 5.79 years) in terms of major adverse cardiovascular events (MACE), all-cause death, and cardiac death among 570 CAD patients with or without CKD and 147 CKD only patients.Results.The all-cause death and cardiac death of the patients with CAD and CKD (24.4% and 20.4%) doubled those of CAD only patients (10.7% and 9.1%) (P<0.001). Long-term statin therapy dramatically reduced the rates of both MACE and all-cause death/cardiac death (by 20.5% and 28.6%/27.7%, resp.) in CAD and CKD patients. CKD only patients had no significant adverse clinical outcomes and were not responsive to long-term statin therapy.Conclusion.Chinese CAD patients with CKD had dramatically high rates of adverse clinical outcomes; for them, long-term statin therapies were exceptionally effective in improving morbidity and mortality. CKD patients who had no cardiovascular disease initially can prognose good clinical outcomes and do not require statin treatment.


Sign in / Sign up

Export Citation Format

Share Document